New Fed Chair Kevin Warsh Faces Potential Headwinds Amid Trumps Policy Legacy EU and Mexico Sign Updated Trade Deal to Reduce Dependence on US and China Inflation Eats Savings The 38 Interest Rate Threshold to Preserve Purchasing Power ICRA Flags Sharp Decline in IBC Recovery Rates to 22 in H2 FY26 Bitcoin Dips Below 76000 as Iran Tensions Rise and ETF Outflows Accelerate Walmart WMT Selected as Top Dividend Stock for Retirement Portfolios Amid Analyst Price Target Adjustments MWH Q1 2026 Earnings EPS Surge of 67 Beats Estimates by Wide Margin HRMY Q1 2026 Earnings EPS Misses Estimates Stock Slips on Profitability Concerns GM Q1 2026 Earnings Blowout EPS Surprise Drives Shares Higher Aditxt Inc ADTX Q3 2025 Earnings Significant Loss Per Share and No Revenue Amid Sharp Stock Decline Golar LNG Ltd GLNG Q1 2026 Earnings EPS Beats Estimates by 245 Revenue Not Disclosed Axsome Therapeutics Holds Near Resistance as Biotech Sector Shows Mixed Signals Eaton Vance TaxAdvantage Global Dividend Opp ETO Edges Higher Testing Key Resistance Zone FG Stock Holds Near Support Amid Quiet Trading Session Allegro MicroSystems ALGM Surges 28 as Bulls Test Key Resistance at 4825 WTW Q1 2026 Earnings EPS Slightly Beats Estimates as Stock Edges Lower Vistagen Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Boosts Investor Sentiment FCX Q1 2026 Earnings Strong Earnings Beat Amid Robust Copper Demand Gamehaus Holdings Inc Q1 2026 Earnings Positive EPS of 004 Drives Share Price Rally USPH Q1 2026 Earnings EPS Misses Estimates by 1725 Stock Declines CAPL Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiencies PL Capital Highlights Growth Potential in Adani Group Stocks Ross Stores ROST Q1 2026 Earnings EPS Surges Past Estimates Despite Muted Revenue Disclosure COCP Q1 2026 Earnings WiderThanExpected Loss Weighs on EarlyStage Biotech Blue Owl Capital Corporation OBDC Q1 2026 Earnings EPS Misses Estimates but Stock Posts Modest Gain HBM Q1 2026 Earnings EPS Beats Estimates as Stock Rallies GXO Logistics Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain FOXF Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Challenges Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment ZYME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss